New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
08:37 EDTCPHDCepheid upgraded at Needham
As previously reported, Needham upgraded Cepheid to Buy from Hold. The firm upgraded shares based on expectations for faster growth driven by recent international launches of HPV and Norovirus, virology expansion, and U.S. sales management changes that should driver faster growth. Price target is $50.
News For CPHD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 16, 2014
17:35 EDTCPHDCepheid 'well positioned' to address Ebola
Subscribe for More Information
17:28 EDTCPHDCepheid sees Q4 adjusted EPS 2c-4c, may not compare to consensus (9c)
Subscribe for More Information
16:11 EDTCPHDCepheid sees FY14 adjusted EPS 11c-13c, may not compare to consensus (52c)
Subscribe for More Information
16:09 EDTCPHDCepheid reports Q3 EPS ex-items 6c, consensus (16c)
Subscribe for More Information
October 14, 2014
07:48 EDTCPHDCepheid recent weakness unjustified, says Canaccord
Subscribe for More Information
October 9, 2014
08:16 EDTCPHDCepheid price target lowered to $54 from $58 at Cowen
Cowen lowered its price target on Cepheid to $54 from $58 ahead of the company's Q3 results. The firm sees a modest upside to estimates and believes the company is well positioned for an acceleration of Commercial growth in 2015. Near term, however, Cowen sees only modest upside, but little risk, and maintains its Outperform rating on Cepheid shares.
07:46 EDTCPHDCepheid initiated with a Buy at Citigroup
Subscribe for More Information
October 8, 2014
07:18 EDTCPHDInfectious Diseases Society of America to hold a conference
ID Week 2014 is being held in Philadelphia on October 8-12.
October 6, 2014
06:02 EDTCPHDCepheid to benefit from stronger than normal flu season, says Piper Jaffray
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use